You just read:

Daratumumab (DARZALEX™) Combined with Standard Treatment for Multiple Myeloma Produced Deep and Durable Responses in Relapsed or Refractory Patients

News provided by

Janssen Research & Development, LLC

Dec 06, 2015, 11:00 ET